ANIK Q1 2017 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q1 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$23M+4.9% YoY

Gross Profit

$17M74.0% margin

Operating Income

$8M34.2% margin

Net Income

$5M23.5% margin

EPS (Diluted)

$0.37

QoQ Revenue Growth

-18.6%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$247M

Total Liabilities

$17M

Stockholders' Equity

$230M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$22M	+4.9%
Gross Profit	$17M	$17M	+2.6%
Operating Income	$8M	$11M	-25.2%
Net Income	$5M	$7M	-20.3%

Geographic Segments

UNITED STATES

$19M87%

Europe

$3M13%